| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 459,0 k € | +7.2% | 428,2 k € | +28.6% | 333,1 k € | +25.7% | 265,0 k € | +48.1% | 179,0 k € | +108.7% | 85,7 k € | +666.9% | 11,2 k € | |
| EBITDA | 458,2 k € | +7.5% | 426,2 k € | +28.5% | 331,8 k € | +25.5% | 264,3 k € | +48.6% | 177,9 k € | +109.9% | 84,7 k € | +745.8% | 10,0 k € | |
| Operating profit | 455,3 k € | +7.2% | 424,9 k € | +28.6% | 330,5 k € | +25.6% | 263,2 k € | +55.0% | 169,8 k € | +119.5% | 77,3 k € | +1067.1% | 6,6 k € | |
| Profit/loss | 345,6 k € | +6.9% | 323,3 k € | +29.1% | 250,4 k € | +24.8% | 200,6 k € | +54.5% | 129,9 k € | +117.3% | 59,8 k € | +1242.6% | 4,5 k € | |
| Equity | 364,6 k € | +6.6% | 342,0 k € | +26.8% | 269,7 k € | +11.7% | 241,4 k € | +13.5% | 212,7 k € | +156.8% | 82,8 k € | +259.3% | 23,1 k € | |
| Total assets | 365,4 k € | +6.6% | 342,8 k € | +26.7% | 270,5 k € | +2.5% | 263,8 k € | -4.2% | 275,3 k € | +118.3% | 126,1 k € | +159.1% | 48,7 k € | |
| Cash | 316,1 k € | +2.8% | 307,4 k € | +17.6% | 261,4 k € | +2.8% | 254,2 k € | -5.1% | 268,0 k € | +137.0% | 113,1 k € | +276.5% | 30,0 k € | |
| Debts | 815,8 € | 0.0% | 815,8 € | +7.2% | 760,7 € | -96.6% | 22,4 k € | -63.7% | 61,7 k € | +45.6% | 42,4 k € | +68.7% | 25,1 k € | |
Private limited company · Brugge · incorporated on 17/06/2019
Private limited company profitable and well capitalised.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dr. Melis en Dr. Vandenbussche is a Private limited company incorporated in 2019. Its main activity is: Hospital activities. Its registered office is in Brugge.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.